Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold... see more

CSE:SONA - Post Discussion

Sona Nanotech Inc > Me too.....a believer??
View:
Post by macdaddio007 on Nov 25, 2020 6:22pm

Me too.....a believer??

There is only one thing that stands out amongst all the BS  that was generated about this company...a couple months ago or slightly less, or maybe more , I dont recall the exact timeline, but when this stock was about to explode the president was asked in an interview what he thought the percentage was of his test being approved by Health Canada and without hesitation he said 100% unequivocally.......nuff said....where are we now
Comment by chris579457 on Nov 25, 2020 7:26pm
if that is accurate then the sales started in September by the insider ,  Filing Date Transaction Date Insider Name Ownership Type Securities Nature of transaction Volume or Value Price Sep 26/20 Sep 22/20 Whittaker, Daniel Davies Indirect Ownership Common ...more  
Comment by Pandora on Nov 25, 2020 7:40pm
"The regulatory approval path for antigen tests is new, with evolving guidelines, and Sona's test is unique, creating a challenging environment for test developers and regulators alike." This statement from the news release sort of suggests the regulators don't completely understand the rapid antigen testing technology and they are continuosly changing the guidelines as they ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities